Integral Ad Science Holding Corp. (NASDAQ:IAS) Receives Consensus Rating of “Moderate Buy” from Analysts

Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $20.72.

Several brokerages have recently weighed in on IAS. TheStreet cut shares of Integral Ad Science from a “c” rating to a “d+” rating in a research report on Wednesday, August 9th. Truist Financial began coverage on shares of Integral Ad Science in a research report on Thursday, July 20th. They set a “buy” rating and a $25.00 price target on the stock. Craig Hallum boosted their price target on shares of Integral Ad Science from $20.00 to $23.00 in a research report on Wednesday, June 14th. Stifel Nicolaus boosted their price target on shares of Integral Ad Science from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Friday, July 21st. Finally, Morgan Stanley reissued an “overweight” rating and set a $21.50 price target on shares of Integral Ad Science in a research report on Friday, August 4th.

Get Our Latest Stock Analysis on Integral Ad Science

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 21,705 shares of the stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $14.67, for a total transaction of $318,412.35. Following the sale, the chief executive officer now owns 107,129 shares of the company’s stock, valued at $1,571,582.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Lisa Utzschneider sold 21,705 shares of the stock in a transaction dated Monday, August 7th. The shares were sold at an average price of $14.67, for a total transaction of $318,412.35. Following the sale, the chief executive officer now owns 107,129 shares of the company’s stock, valued at $1,571,582.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Tom Sharma sold 9,646 shares of the stock in a transaction dated Monday, May 22nd. The stock was sold at an average price of $17.41, for a total transaction of $167,936.86. Following the sale, the insider now directly owns 45,393 shares in the company, valued at approximately $790,292.13. The disclosure for this sale can be found here. Insiders sold a total of 5,278,638 shares of company stock valued at $95,600,016 over the last 90 days. 2.00% of the stock is owned by company insiders.

Institutional Trading of Integral Ad Science

Hedge funds have recently added to or reduced their stakes in the company. Lisanti Capital Growth LLC acquired a new stake in Integral Ad Science during the first quarter worth approximately $2,217,000. Los Angeles Capital Management LLC raised its holdings in Integral Ad Science by 14.5% during the fourth quarter. Los Angeles Capital Management LLC now owns 36,670 shares of the company’s stock worth $322,000 after purchasing an additional 4,648 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in Integral Ad Science by 114.4% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 30,568 shares of the company’s stock worth $436,000 after purchasing an additional 16,313 shares in the last quarter. Richelieu Gestion PLC raised its holdings in Integral Ad Science by 27.7% during the first quarter. Richelieu Gestion PLC now owns 18,670 shares of the company’s stock worth $266,000 after purchasing an additional 4,047 shares in the last quarter. Finally, Strs Ohio raised its holdings in Integral Ad Science by 123.1% during the fourth quarter. Strs Ohio now owns 11,600 shares of the company’s stock worth $101,000 after purchasing an additional 6,400 shares in the last quarter. Institutional investors and hedge funds own 96.39% of the company’s stock.

Integral Ad Science Trading Down 1.5 %

Shares of IAS opened at $13.86 on Friday. Integral Ad Science has a 52-week low of $6.63 and a 52-week high of $20.88. The company has a quick ratio of 3.80, a current ratio of 3.80 and a debt-to-equity ratio of 0.22. The firm’s fifty day moving average is $17.87 and its two-hundred day moving average is $15.50. The stock has a market cap of $2.17 billion, a PE ratio of 99.00 and a beta of 1.61.

Integral Ad Science (NASDAQ:IAS – Get Free Report) last announced its earnings results on Thursday, August 3rd. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.02. Integral Ad Science had a net margin of 5.26% and a return on equity of 2.81%. The company had revenue of $113.65 million for the quarter, compared to analysts’ expectations of $112.41 million. During the same quarter in the previous year, the company posted $0.01 EPS. The firm’s quarterly revenue was up 13.3% on a year-over-year basis. Research analysts forecast that Integral Ad Science will post 0.07 earnings per share for the current fiscal year.

About Integral Ad Science

(Get Free Report

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Germany, Italy, Singapore, Australia, France, Japan, and India. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Further Reading

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Integral Ad Science, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Integral Ad Science wasn’t on the list.

While Integral Ad Science currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Pot Stock Investing Cover

Click the link below and we’ll send you MarketBeat’s guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Source link